Sg Americas Securities, LLC Vista Gen Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$0.12 - $0.3 $7,244 - $18,111	60,370 Added 284.39%	81,598 $10,000
Q4 2022 Feb 02, 2023	SELL	$0.09 - $0.16 $8,792 - $15,630	-97,690 Reduced 82.15%	21,228 $2,000
Q3 2022 Oct 31, 2022	BUY	$0.14 - $1.07 $12,526 - $95,738	89,475 Added 303.89%	118,918 $18,000
Q2 2022 Jul 29, 2022	SELL	$0.88 - $1.73 $78,948 - $155,205	-89,714 Reduced 75.29%	29,443 $26,000
Q1 2022 Apr 29, 2022	BUY	$1.14 - $2.09 $89,714 - $164,476	78,697 Added 194.51%	119,157 $148,000

Q4 2021 Feb 07, 2022	SELL	$1.67 - $2.76 $59,226 - $97,883	-35,465 Reduced 46.71%	40,460 $79,000
Q3 2021 Nov 01, 2021	BUY	$2.62 - $3.45 $198,923 - $261,941	75,925 New	75,925 $208,000
Q1 2021 May 13, 2021	SELL	$1.89 - $2.96 $27,783 - $43,512	-14,700 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$0.65 - $1.94 $9,555 - $28,518	14,700 New	14,700 $29,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $720M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.